Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction.

Javed ButlerMilton PackerGerasimos S Filippatos Joao Pedro Ferreira Cordula Zeller Janet Schnee Martina BrueckmannStuart J PocockFaiez ZannadStefan D Anker

Published in: European heart journal (2021)

The consistency of the response in patients with ejection fractions of <25% to <65% distinguishes the effects of empagliflozin from other drugs that have been evaluated across the full spectrum of ejection fractions in patients with heart failure.

Keyphrases

ejection fraction
aortic stenosis
left ventricular
transcatheter aortic valve replacement
heart failure
hypertrophic cardiomyopathy
aortic valve
mitral valve
coronary artery disease
atrial fibrillation
drug induced